News &amp; Updates

The use of painkillers at low doses by men does not hurt their chances of getting their partners pregnant, a study suggests.

Low-dose analgesics not a threat to male fecundity

Arbidol prevents COVID-19 infections in health professionals

Prophylactic oral arbidol appears to reduce infection with SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), among frontline health professionals, suggests a study.

Arbidol prevents COVID-19 infections in health professionals

BRCA mutations do not up risk of colorectal cancer

Carriers of the BRCA1 and/or BRCA2 mutation do not appear to be at increased risk of colorectal cancer, according to the results of a recent systematic review and meta-analysis.

BRCA mutations do not up risk of colorectal cancer

Nivolumab fails to deliver OS benefit for recurrent glioblastoma

The PD-1 inhibitor nivolumab did not improve overall survival (OS) in patients with recurrent glioblastoma compared with bevacizumab, the phase III CheckMate 143* trial has shown, highlighting the need for new therapeutic interventions for this disease.

Nivolumab fails to deliver OS benefit for recurrent glioblastoma

NLR, PLR ratios affect left ventricular thrombosis resolution after AMI

High neutrophil-to-lymphocyte (NLR) and platelet-to-lymphocyte (PLR) ratios may be indicative of a failure to resolve left ventricular thrombosis (LVT) in postacute myocardial infarction (post-AMI) patients not receiving percutaneous coronary intervention (PCI), according to a new Singapore study.

NLR, PLR ratios affect left ventricular thrombosis resolution after AMI

Copper IUD raises risk of bacterial vaginosis

The nonhormonal contraceptive copper intrauterine device (IUD) carries an increased hazard of bacterial vaginosis that remains elevated through up to 18 months of use but returns to pre-initiation levels following discontinuation, a study has found.

Copper IUD raises risk of bacterial vaginosis

Oral minoxidil proven safe, effective for treating alopecia

Use of low-dose oral minoxidil is safe and effective in the treatment of androgenic alopecia and alopecia areata, in addition to demonstrating a big advantage over the topical formulation in terms of convenience and patient compliance, as reported in a systematic review.

Oral minoxidil proven safe, effective for treating alopecia

Pre-hospital loading with ticagrelor/prasugrel trumps clopidogrel in STEMI patients

Pre-hospital loading with ticagrelor or prasugrel reduces infarct size and greater myocardial salvage index in patients with ST-elevation myocardial infarction (STEMI) relative to clopidogrel, a recent study has found.

Pre-hospital loading with ticagrelor/prasugrel trumps clopidogrel in STEMI patients

Atropine 0.05% trumps 0.01% concentration in slowing myopia progression

Atropine 0.05% has double the efficacy of 0.01% eye drops over 2 years, and the former remains the optimal concentration among atropine concentrations in slowing the progression of myopia, a recent study has shown.

Atropine 0.05% trumps 0.01% concentration in slowing myopia progression

Sleep disruptions common in women with or without nocturia

Nocturnal bladder symptoms are not the primary cause of poor sleep in women with overactive bladder, suggest the results of a recent study.

Sleep disruptions common in women with or without nocturia